Clinical Relevance and Human Trials Clinical trials have explored the administration of BPC 157 at a dosage of 200 g per person per day via intramuscular injection for a duration of 7 days
At hormonal levels, Copper Tripeptide-1 acts as a chemoattractant for fibroblasts (repairing cells) and activates a plethora of regenerative processes in the skin, such as angiogenesis, production of extracellular matrix components, including collagen, elastin, proteoglycans, glycosaminoglycans, etc, additionally activating metalloproteinases (MMPs) involved in tissue remodeling
doi: 10.1016/s0140-6736(05)78428-2
This makes it harder to make sure that everyone gets the same amount
24(18):19721989 BPC 157 and standard angiogenic growth factors: gastrointestinal tract healing and lessons from musculoskeletal tissue models Disclaimer: This product is intended for laboratory research use only (RUO)
[DOI] [PMC free article] [PubMed] [Google Scholar] 408.McClorry S., Slupsky C.M., Lind T., Karlsland keson P., Hernell O., hlund I